Systemic Lupus Erythematosus

Drug-induced lupus and systemic lupus erythematosus (SLE) are two entirely different entities. Failure to identify SLE could lead to worsening symptoms, researchers say.

A new study published online ahead of print in Arthritis Care & Research sheds light on the barriers rheumatology patients face with regards to smoking cessation while describing individual reactions to cessation protocols and identifying patient centered outcomes after improvements in care.

Using a frailty index to predict adverse outcomes and mortality in systemic lupus erythematosus proves to be feasible and effective in a study. The test, SLICC-FI, correlated well with existing measures of SLE disease activity, organ damage and HRQoL.

A recent study published in Arthritis & Rheumatology has demonstrated that belimumab is both safe and effective in patients with systemic lupus erythematosus and provides disease control over the long term.

Higher lupus disease activity may be associated with bacteria from periodontal disease, which may be an important modifiable mediator of SLE disease activity.

In this quiz, we revisit recent advances made in systemic lupus erythematosus (SLE).

Increased cancer risk, a new measure for disease outcomes and a new treatment are among the developments in systemic lupus erythematosus (SLE) published in recent months. Learn more in this slideshow.

This meta-analysis confirms and clarifies the link between SLE and certain types of cancer.

Test your knowledge of the featured topics and findings reported at rheumatology’s annual educational gathering.

How to ensure your patients with lupus receive the vaccines they need.

Take this 6-question quiz to test your knowledge of current recommendations for CV risk assessment, cancer screening, and immunization in patients with lupus.

The pros and cons of HCQ dosing guidelines to limit potential eye toxicity were explored at this year’s ACR/ARHP Annual Meeting.

Take the quiz to see how much you know about SLE-related complications during pregnancy.

Canadian researchers have identified predictors of subclinical cardiomyopathy in patients with lupus.

(1) Menopause worsens RA symptoms; (2) obesity increases disease activity in women with lupus; and (3) signs of cardiac disease appear early in SLE.

This complication occurs in up to 44% of patients with systemic lupus erythematosus.

Two recent studies underscore the key role of interferon in SLE; a third trial identifies a link between undiagnosed vertebral fractures and organ damage in women with lupus.

Two sets of diagnostic criteria for lupus go head to head in a recent meta-analysis.

Test your knowledge of the assessment and follow-up of patients with SLE with 7 questions based on recent British Society for Rheumatology guidelines.

Your patient is a young woman who presents with a facial rash, joint pain, and fatigue. How will you proceed?

A potentially modifiable target for improving outcomes in patients with lupus.

Brush up on the diagnosis of systemic lupus erythematosus with 5 questions based on the recent British Society for Rheumatology guidelines.

Pregnancy in a patient with SLE should be considered high risk by definition.

Researchers have set their sights on macrophage activation syndrome, pathways identified in renal cells, and mechanistic target of rapamycin.

Which symptoms of SLE have the greatest impact on quality of life? What are the most common comorbid emotional disorders? Answers here.